US          Europe          Arab          Asia          Africa    
|      Politics          Economy     Oil&Energy         
                 Entertainment          Sport

Japan's Sankyo Acquires US Pharmaceutical Firm for 410 Million


9/29/2014 9:29:49 PM

(MENAFN- Qatar News Agency) Tokyo September 29 (QNA) - Japanese pharmaceutical company Daiichi Sankyo Co. announced Monday it had agreed to acquire US company Ambit Biosciences for $410 million.

The company said the move was a bid to establish its presence in the oncology field. Oncology is a branch in medicine that deals with tumors.

The Japanese company will need to spend $315 million to acquire all the stocks of Ambit Biosciences a joint statement said. Sankyo President Joji Nakayama said in the statement that the move will ensure Sankyo will continue to provide innovative pharmaceuticals in areas that are unmet in terms of medical need. (QNA)


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Tags

Label

Comments

No comment

Category

Date

More Stories

Newsletter


Search